Main View
This view is used for searching all possible sources.
First Page Previous Page 1 Next Page Last Page
 
1
Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management
2010-02-01

Good glycaemic control continues to be the most effective therapeutic manoeuvre to reduce the risk of development and/or progression of microvascular disease, and therefore remains the cornerstone of diabetes management despite recent scepticism about tight glucose control strategies. The impact on macrovascular complications is still ...

PubMed Central

2
Glycaemic goals in patients with type 2 diabetes: current status, challenges and recent advances.
2010-06-01

Recommendations for the management of type 2 diabetes include rigorous control of blood glucose levels and other risk factors, such as hypertension and dyslipidaemia. In clinical practice, many patients do not reach goals for glycaemic control. Causes of failure to control blood glucose include progression of ...

PubMed

3
Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol
2007-07-10

IntroductionA single centre has reported that implementation of an intensive insulin protocol, aiming for tight glycaemic control (blood glucose 4.4 to 6.1 mmol/l), resulted in significant reduction in mortality in longer stay medical and surgical critically ill patients. Our aim was to determine the degree to which tight glycaemic ...

PubMed Central

4
Preventing glycaemic relapse in recently controlled type 2 diabetes patients: a randomised controlled trial
2010-01-19

Aims/hypothesisAfter achieving glycaemic control, many type 2 diabetic patients relapse to clinically significant levels of hyperglycaemia. We sought to determine the optimal frequency of telephone contact by nurse practitioners that was necessary to prevent glycaemic relapse.MethodsThis parallel, randomised ...

PubMed Central

5
A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na�ve type 2 diabetes mellitus patients.
2011-11-01

Aim: The purpose of this study was to evaluate if superior glycaemic control could be achieved with Avandamet� (rosiglitazone/metformin/AVM) compared with metformin (MET) monotherapy, and if glycaemic effects attained with AVM are durable over 18 months of treatment. Bone mineral density (BMD) and bone biomarkers ...

PubMed

6
Glycaemic control in diabetic nephropathy.
1984-04-21

To investigate the quality of glycaemic control that is achievable in diabetic patients with persistent proteinuria and asymptomatic but declining renal function three matched groups of patients were studied. The first comprised diabetics with proteinuria receiving continuous subcutaneous insulin infusion; the second, diabetics without ...

PubMed Central

7
Tight Glycaemic Control During Cardiac Surgery
2010-10-20

Nosocomial Infection; Interleukines; Glycemic Control; Cardiac Surgery With Cardiopulmonary Bypass Circuit

ClinicalTrials.gov

8
Assessing glycaemic control: self-monitoring of blood glucose.

Diabetes Mellitus is a chronic, lifelong metabolic disorder characterized by an elevated blood glucose level resulting from an absolute or relative shortage of insulin. Self-monitoring of blood glucose (SMBG) has escalated over the years following the outcomes of evidence demonstrating a strong correlation between tight blood glucose control and the significant reduction of ...

PubMed

First Page Previous Page 1 Next Page Last Page